ProKidney Corp.
PROK
$1.08
$0.054.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 76.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.00K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 76.00K | -- | -- | -- | -- |
| SG&A Expenses | 11.87M | 12.40M | 13.65M | 12.84M | 1.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.65M | 43.65M | 43.06M | 40.08M | 24.21M |
| Operating Income | -51.57M | -43.65M | -43.06M | -40.08M | -24.21M |
| Income Before Tax | -46.78M | -43.40M | -38.52M | -35.24M | -18.93M |
| Income Tax Expenses | 1.70M | -2.34M | -56.00K | 98.00K | 2.79M |
| Earnings from Continuing Operations | -48.48M | -41.05M | -38.47M | -35.33M | -21.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 27.21M | 23.14M | 25.96M | 25.84M | 16.02M |
| Net Income | -21.28M | -17.91M | -12.51M | -9.49M | -5.70M |
| EBIT | -51.57M | -43.65M | -43.06M | -40.08M | -24.21M |
| EBITDA | -50.00M | -42.16M | -41.79M | -38.97M | -23.06M |
| EPS Basic | -0.17 | -0.14 | -0.16 | -0.16 | -0.09 |
| Normalized Basic EPS | -0.02 | -0.01 | 0.02 | 0.06 | 0.07 |
| EPS Diluted | -0.17 | -0.14 | -0.16 | -0.16 | -0.09 |
| Normalized Diluted EPS | -0.02 | -0.01 | 0.02 | 0.06 | 0.07 |
| Average Basic Shares Outstanding | 128.21M | 126.17M | 75.91M | 60.95M | 62.16M |
| Average Diluted Shares Outstanding | 128.21M | 126.17M | 75.91M | 60.95M | 62.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |